sulfamethoxazole has been researched along with Primary Peritonitis in 11 studies
Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The extensive use of invasive procedures and of long-term norfloxacin prophylaxis in the management of cirrhotic patients may have influenced the epidemiology of bacterial infections in cirrhosis." | 7.71 | Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. ( Arroyo, V; Colmenero, J; Fernández, J; Gómez, J; Navasa, M; Rodés, J; Vila, J, 2002) |
| " The dosage yielded too high plasma trimethoprim concentrations, while sulfamethoxazole dialysate concentrations were too low." | 5.27 | Pharmacokinetics of cefradine, sulfamethoxazole and trimethoprim and their metabolites in a patient with peritonitis undergoing continuous ambulatory peritoneal dialysis. ( Berden, JH; Hekster, YA; Martea, M; Voets, AJ; Vree, TB, 1987) |
| "Vancomycin was found to be appropriate in particular because of the resistance characteristics of bacterial isolates." | 5.27 | [Treatment of peritonitis during continuous ambulatory peritoneal dialysis (CAPD) with co-trimoxazole, cefazolin or vancomycin]. ( Binswanger, U; König, U; Müller, U, 1987) |
| "The extensive use of invasive procedures and of long-term norfloxacin prophylaxis in the management of cirrhotic patients may have influenced the epidemiology of bacterial infections in cirrhosis." | 3.71 | Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. ( Arroyo, V; Colmenero, J; Fernández, J; Gómez, J; Navasa, M; Rodés, J; Vila, J, 2002) |
| " Testing of biological activity revealed limited potential for resistance to these agents, low toxicity, and highly effective in vivo activity, even with low dosing regimens." | 1.40 | Antibacterial activity of a series of N2,N4-disubstituted quinazoline-2,4-diamines. ( Burda, WN; Fleeman, R; Manetsch, R; Shaw, LN; Van Horn, KS, 2014) |
| "It is concluded that initial treatment of CAPD peritonitis with co-trimoxazole is justified by the high proportion of sensitive germs and that it represents a safe, efficient and inexpensive treatment." | 1.27 | Treatment of peritonitis in continuous ambulatory peritoneal dialysis patients with co-trimoxazole. ( Favre, H; Glasson, P, 1984) |
| " The dosage yielded too high plasma trimethoprim concentrations, while sulfamethoxazole dialysate concentrations were too low." | 1.27 | Pharmacokinetics of cefradine, sulfamethoxazole and trimethoprim and their metabolites in a patient with peritonitis undergoing continuous ambulatory peritoneal dialysis. ( Berden, JH; Hekster, YA; Martea, M; Voets, AJ; Vree, TB, 1987) |
| "Vancomycin was found to be appropriate in particular because of the resistance characteristics of bacterial isolates." | 1.27 | [Treatment of peritonitis during continuous ambulatory peritoneal dialysis (CAPD) with co-trimoxazole, cefazolin or vancomycin]. ( Binswanger, U; König, U; Müller, U, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (81.82) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Van Horn, KS | 1 |
| Burda, WN | 1 |
| Fleeman, R | 1 |
| Shaw, LN | 1 |
| Manetsch, R | 1 |
| Glasson, P | 1 |
| Favre, H | 1 |
| Winslow, DL | 1 |
| Steele, ML | 1 |
| de Fremont, JF | 1 |
| Schmit, JL | 1 |
| Thomas, D | 1 |
| Coevoet, B | 1 |
| Eb, F | 1 |
| Laurence, G | 1 |
| Orfila, J | 1 |
| Fournier, A | 1 |
| Singlas, E | 1 |
| Colin, JN | 1 |
| Rottembourg, J | 1 |
| Meessen, JP | 1 |
| de Martin, A | 1 |
| Legrain, M | 1 |
| Simon, P | 1 |
| Fernández, J | 1 |
| Navasa, M | 1 |
| Gómez, J | 1 |
| Colmenero, J | 1 |
| Vila, J | 1 |
| Arroyo, V | 1 |
| Rodés, J | 1 |
| Tally, FP | 1 |
| Gorbach, SL | 1 |
| Morris, AJ | 1 |
| Henderson, GK | 1 |
| Bremner, DA | 1 |
| Collins, JF | 1 |
| Martea, M | 1 |
| Hekster, YA | 1 |
| Vree, TB | 1 |
| Voets, AJ | 1 |
| Berden, JH | 1 |
| König, U | 1 |
| Müller, U | 1 |
| Binswanger, U | 1 |
| Roosen, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Patterns of Antibiotic Resistant Bacterial Infections in Liver Intensive Care Unit[NCT03855709] | 200 participants (Anticipated) | Observational | 2019-05-31 | Not yet recruiting | |||
| Comparison of 3 Days and 7 Days Intravenous Ceftriaxone Prophylaxis in Patients With Acute Variceal Bleeding[NCT00838864] | Phase 4 | 79 participants (Actual) | Interventional | 2009-03-31 | Completed | ||
| Comparison of Daily Norfloxacin Versus Weekly Ciprofloxacin for the Prevention of Spontaneous Bacterial Peritonitis in Cirrhotic Patients[NCT01542801] | Phase 4 | 124 participants (Actual) | Interventional | 2011-08-31 | Completed | ||
| Rifaximin Versus Norfloxacin in the Primary Prophylaxis of Spontaneous Bacterial Peritonitis[NCT04159870] | Phase 3 | 322 participants (Anticipated) | Interventional | 2019-11-05 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for sulfamethoxazole and Primary Peritonitis
| Article | Year |
|---|---|
Antibiotics in surgery.
Topics: Anti-Bacterial Agents; Bacterial Infections; Biliary Tract Diseases; Burns; Catheterization; Cephalo | 1975 |
10 other studies available for sulfamethoxazole and Primary Peritonitis
| Article | Year |
|---|---|
Antibacterial activity of a series of N2,N4-disubstituted quinazoline-2,4-diamines.
Topics: Animals; Anti-Bacterial Agents; Diamines; Disease Models, Animal; Hemolysis; Humans; Larva; Microbia | 2014 |
Treatment of peritonitis in continuous ambulatory peritoneal dialysis patients with co-trimoxazole.
Topics: Adult; Aged; Anti-Infective Agents, Urinary; Bacterial Infections; Drug Combinations; Female; Humans | 1984 |
Listeria bacteremia and peritonitis associated with a peritoneovenous shunt: successful treatment with sulfamethoxazole and trimethoprim.
Topics: Aged; Humans; Listeriosis; Male; Peritoneovenous Shunt; Peritonitis; Postoperative Complications; Se | 1984 |
[Treatment of peritonitis in continuous ambulatory peritoneal dialysis ].
Topics: Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Candidiasis; Drug Combinations; Humans; Kidney F | 1982 |
Pharmacokinetics of sulfamethoxazole--trimethoprim combination during chronic peritoneal dialysis: effect of peritonitis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Drug Combinations; Female; Humans; Kidney Failure, Ch | 1982 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escher | 2002 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escher | 2002 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escher | 2002 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escher | 2002 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escher | 2002 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escher | 2002 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escher | 2002 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escher | 2002 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escher | 2002 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escher | 2002 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escher | 2002 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escher | 2002 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escher | 2002 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escher | 2002 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escher | 2002 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escher | 2002 |
Relapsing peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis due to Corynebacterium aquaticum.
Topics: Adult; Anti-Bacterial Agents; Corynebacterium; Corynebacterium Infections; Diabetic Nephropathies; D | 1986 |
Pharmacokinetics of cefradine, sulfamethoxazole and trimethoprim and their metabolites in a patient with peritonitis undergoing continuous ambulatory peritoneal dialysis.
Topics: Anti-Infective Agents, Urinary; Cephalosporins; Cephradine; Drug Combinations; Half-Life; Humans; Ki | 1987 |
[Treatment of peritonitis during continuous ambulatory peritoneal dialysis (CAPD) with co-trimoxazole, cefazolin or vancomycin].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aspergillus; Bacteria; Candida; Cefazolin; Drug Combin | 1987 |
[Clinical experience with the combination of sulfamethoxazole and trimethoprim in gynecology and obstetrics].
Topics: Administration, Oral; Adult; Aged; Drug Synergism; Endometritis; Female; Folic Acid Antagonists; Gen | 1971 |